In the Race to Combat Climate Change, C.H. Robinson Sees 654% Increase in Renewables Business While the Booming Clean Energy Sector Faces Five Key Logistics Challenges
24.6.2021 14:00:00 EEST | Business Wire | Press release
At a time when world leaders are setting aggressive goals to fight climate change, global logistics company C.H. Robinson is realizing triple-digit growth in its renewable-energy logistics business and helping the renewables industry cope with five key challenges. Feeding the demand for wind and solar power depends not only on overcoming today’s global supply-chain disruptions, but also reducing the risks, damages, complexities and costs inherent to projects that stretch into some of the most remote places on Earth.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210624005350/en/
C.H. Robinson helps renewable-energy companies manage the supply chain and logistics for complex projects in some of the most remote places on Earth. (Photo: Business Wire)
C.H. Robinson, which manages renewable-energy transportation and logistics from manufacturing to installation to recycling, has seen its renewables business soar 654% globally in just the past three years. This work will create 14,000 megawatts of energy – enough solar energy to charge 1.73 million electric cars and enough wind energy to power a city the size of London for four months.
Growth in renewables is being fueled by the 194 nations of the Paris climate accord pledging to reduce greenhouse gases, tech advances lowering the cost of renewables compared to fossil fuels, and utilities and the business community investing more in clean energy sources. Tax incentives in the United States have also attracted new investors. The recent extension of those tax credits and the Biden administration proposing $2 trillion in climate-related spending are likely to propel the U.S. market for the next few years. Globally, investment in the sector is expected to grow sevenfold, reaching $2.15 trillion in 2025.
“The stakes are too high for these complex projects not to succeed,” said Mike Short, C.H. Robinson’s President of Global Forwarding. “The gap between sustainability goals and enough renewable energy to meet those goals can only be filled with a viable supply chain. That supply chain stretches across continents, from mines to manufacturing plants to some of the most remote places on Earth. Wind farms are being built in the ocean. Solar farms with millions of panels are rising in the desert. Just to make a solar panel, roughly 40 different components need to get to the factory, including precious metals. These projects are built on tight timelines and budgets, and companies risk millions in unexpected costs if there are delays anywhere along the way.”
Five supply-chain barriers pose the biggest threats to keeping up with the world’s demand for green energy:
- Special equipment needs: Wind turbines keep getting bigger, with some as tall as an 85-story building. The sweep of the blades is more than an acre. Moving oversized parts requires both special expertise and equipment, including flatbed trucks that are in exceptionally short supply. This year has seen load-to-truck ratios over 100:1, meaning 100 loads waiting to be delivered for every flatbed truck available. Solar equipment, on the other hand, has sensitive electronics and glass easily subject to damage, and is also competing for transportation capacity amid one of the tightest markets in history.
- Unpredictability: Five years ago, the movement of goods such as solar panels out of Asia was high volume, low cost. Now, ship capacity is scarce and more expensive because of fewer shipping lines and a global container shortage. Port congestion makes it harder to know when your vessel will arrive, when freight will be unloaded or when enough truck chassis will be available to move it.
- Global supply chain visibility: If 45 containers a day need to arrive at a project site from different origins, knowing each load’s location at any time is critical for contingency planning, timeline management, cost mitigation, and decision-making such as whether 25 or 75 workers are needed at an installation site on any given day. Without centralized visibility and management, blind spots fuel more unpredictability and projects become subject to disparate processes across multiple vendors.
- Tighter budgets: Rising costs– from polysilicon used in solar panels to aluminum to freight charges – are adding pressure to the profitability of projects. Unexpected costs when projects don’t go as planned, like parts arriving late or damaged, can then erase profit margins. Fines are a constant threat.
- Strict timelines: Because developers and investors are hurrying to get projects started in order to meet the deadlines for tax credits, they build in contract penalties that can add up to six or seven figures for parts or equipment delivered late. Also, the nature of these vast, one-time projects makes them vulnerable to lack of resources and infrastructure to meet their needs quickly enough, especially in remote areas.
Renewable-energy companies and investors rely on C.H. Robinson not just to manage transportation, but also to provide the planning, project management, customs expertise, warehousing and on-site logistics to get clean energy projects off the ground.
“NextEnergy Capital has built, owns and operates more than 1.5 gigawatts of solar electric power plants across the world,” said Filinto Martin, Managing Director of NPIII, a NextEnergy Capital fund. “We recently had nearly 200 containers of solar panels arriving to the East Coast of the United States from Asia, with the equipment destined for two different sites. We entrusted C.H. Robinson to find local warehousing and track the inventory until the project sites were ready.”
C.H. Robinson has also helped
- A renewable-energy developer get 2,000 acres of solar panels delivered on time and on budget for a global beverage company to fulfill a sustainability pledge
- A manufacturer lower its damaged shipments to 1% and raise on-time delivery to 99%
- A manufacturer avoid penalties of up to $10,000 per load per day
“These companies cannot afford any black holes in the process, especially during one of the most volatile markets in history,” said C.H. Robinson renewables expert Jim Mancini, the vice president who oversees the company's services and technology for the energy sector. “That’s why we work to anticipate every contingency and offer visibility through our single, global multimodal technology platform, Navisphere. To keep these complex projects on track, it’s crucial to ensure that parts are where they need to be, the right transportation and specialized equipment are available, and the finished product arrives to the project site when on-the-ground teams are ready to receive and install. We are proud to leverage our scale and global suite of services to help renewable-energy companies protect and preserve our planet.”
About C.H. Robinson
C.H. Robinson solves logistics problems for companies across the globe and across industries, from the simple to the most complex. With $21 billion in freight under management and 19 million shipments annually, we are one of the world’s largest logistics platforms. Our global suite of services accelerates trade to seamlessly deliver the products and goods that drive the world’s economy. With the combination of our multi-modal transportation management system and expertise, we use our information advantage to deliver smarter solutions for our more than 105,000 customers and 73,000 contract carriers. Our technology is built by and for supply chain experts to bring faster, more meaningful improvements to our customers’ businesses. As a responsible global citizen, we are also proud to contribute millions of dollars to support causes that matter to our company, our Foundation and our employees. For more information, visit chrobinson.com (Nasdaq: CHRW).
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210624005350/en/
Contact information
Kelsey Soby, kelsey.soby@chrobinson.com
Kaelan Richards, krichards@bpimedia.com, 617-777-3883
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release
Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 14:30:00 EEST | Press release
Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European Society for Medical Oncology (ESMO) Congress, showed the study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Gastric cancer is a leading cause of cancer-related death worldwide, and outcomes are particularly poor once the disease is advanced.1 Because treatment options are limited for people whose cancer continues to progress after multiple therapies, there is a significant need for new targeted therapies.2 CLDN18.2, a protein found at abnormally high levels on the surface of certain cancer cells, has emerged as a key biomarke
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
